Rapid response of cutaneous lupus erythematosus to treatment with the type 1 interferon receptor antagonist anifrolumab.

Authors	Claudia Günther
Journal	The British journal of dermatology (Br J Dermatol) Vol. 189 Issue 2 Pg. 151-153 (07 17 2023) ISSN: 1365-2133 [Electronic] England
PMID	37002783 (Publication Type: Editorial, Comment)
Chemical References	anifrolumab Receptors, Interferon Biomarkers
Topics	Humans Transcriptome Lupus Erythematosus, Cutaneous (drug therapy) Receptors, Interferon Biomarkers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!